According to GlobalData’s company profile on Arvinas, Cancer treatment biomarkers was a key innovation area identified from patents. Arvinas‘s grant share as of January 2024 was 18%. Grant share is based on the ratio of number of grants to total number of patents.
Treatment of prostate cancer with specific compounds
A recently granted patent (Publication Number: US11883393B2) discloses claims related to a compound, pharmaceutically acceptable salts of the compound, and pharmaceutical compositions containing the compound or its salts. Claim 1 pertains to the compound itself, while Claim 2 covers pharmaceutically acceptable salts of the compound. This indicates the potential for the compound to be used in various pharmaceutical applications due to its properties or characteristics.
Furthermore, Claims 3 and 4 focus on pharmaceutical compositions comprising the compound or its pharmaceutically acceptable salts along with one or more pharmaceutically acceptable excipients. This suggests that the patent not only protects the compound itself but also its formulation in pharmaceutical compositions, highlighting the potential for the development of new drugs or therapies. Overall, the granted patent provides protection for the compound, its salts, and their use in pharmaceutical compositions, paving the way for potential advancements in the field of medicine and healthcare.
To know more about GlobalData’s detailed insights on Arvinas, buy the report here.
From 
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies